Overexpression of biglycan in the heart of transgenic mice: An antibody microarray study

Journal of Proteome Research

Volumn 6, Issue 2, 2007, Pages 854-861

  Bereczki, Erika ^a   Gonda, Szilvia ^a   Csont, Tamás ^b   Korpos, Eva ^a   Zvara, Agnes ^a   Ferdinandy, Péter ^b   Sántha, Miklós ^a,c  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

^c INSTITUTE OF BIOCHEMISTRY   (Hungary)

Author keywords

Antibody microarray; Biglycan; Cardiac protein profile; Transgenic mice

Indexed keywords

BIGLYCAN; CADHERIN; CALMODULIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FOCAL ADHESION KINASE 2; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOENZYME; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN MCL 1; RAF PROTEIN; SYNAPTOTAGMIN; SYNTROPHIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY MICROARRAY; ARTICLE; CALCIUM SIGNALING; DOWN REGULATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEART; HEART PROTECTION; HEART VENTRICLE REMODELING; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEOMICS; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; AORTA; CARDIOTONIC AGENTS; EXTRACELLULAR MATRIX PROTEINS; HEART; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH; PROTEIN ARRAY ANALYSIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

MUS MUSCULUS;

EID: 33847363982     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060571b     Document Type: Article

References (67)

1. Fisher, L. W.; Termine, J. D.; Young, M. F. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem. 1989, 264 (8), 4571-4576.
2. Ameye, L.; Young, M. F. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12 (9), 107R-116R.
3. Iozzo, R. V. Matrix proteoglycans: From Molecular Design to Cellular Function. Annu. Rev. Biochem. 1998, 67 (1), 609-652.
4. Tufvesson, E.; Malmstrom, J.; Marko-Varga, G.; Westergren-Thorsson, G. Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. Eur. J. Biochem. 2002, 269 (15), 3688-3696.
5. Grande-Allen, K. J.; Calabro, A.; Gupta, V.; Wight, T. N.; Hascall, V. C.; Vesely, I. Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordae: association with regions of tensile and compressive loading. Glycobiology 2004, 14 (7), 621-633.
6. Ruoslahti, E.; Yamaguchi, Y. Proteoglycans as modulators of growth factor activities. Cell 1991, 64 (5), 867-869.
7. McBride, O. W.; Fisher, L. W.; Young, M. F. Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively. Genomics 1990, 6 (2), 219-225.
8. Traupe, H.; Van den Ouweland, A. M. W.; Van Oost, B. A.; Vogel, W.; Vetter, U.; Warren, S. T.; Rocchi, M.; Darlison, M. G. and others. Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. Genomics 1992, 13 (2), 481-483.
9. Fedarko, N. S.; Termine, J. D.; Young, M. F.; Robey, P. G. Temporal regulation of hyaluronan and proteoglycan metabolism by human bone-cells invitro. J. Biol. Chem. 1990, 265 (21), 12200-12209.
10. Klezovitch, O.; Scanu, A. M. Domains of Apolipoprotein E. Involved in the Binding to the Protein Core of Biglycan of the Vascular Extracellular Matrix: Potential Relationship between Retention and Anti-Atherogenic Properties of this Apolipoprotein. Trends Cardiovasc. Med. 2001, 11 (7), 263-268.
11. Latif, N.; Sarathchandra, P.; Taylor, P. M.; Antoniw, J.; Yacoub, M. H. Localization and pattern of expression of extracellular matrix components in human heart valves. J. Heart Valve Dis. 2005, 14 (2), 542-548.
12. Wight, T. N.; Kinsella, M. G.; Qwarnstrom, E. E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Op. Cell Biol. 1992, 4 (5), 793-801.
13. Camejo, G.; Hurt-Camejo, E.; Wiklund, O.; Bondjers, G. Association of apo B lipoproteins with arterial proteoglycans: Pathological significance and molecular basis. Atherosclerosis 1998, 139 (2), 205-222.
14. Hildebrand, A.; Romaris, M.; Rasmussen, L. M.; Heinegard, D.; Twardzik, D. R.; Border, W. A.; Rouslahti, E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 1994, 302 (2), 527-534.
15. Tufvesson, E.; Westergren-Thorsson, G. Tumour necrosis factor-alpha interacts with biglycan and decorin. Febs Lett. 2002, 530 (1-3), 124-128.
16. Bidanset, D. J.; Guidry, C.; Rosenberg, L. C.; Choi, H. U.; Timpl, R.; Hook, M. Binding of the proteoglycan decorin to collagen type- VI. J. Biol. Chem. 1992, 267 (8), 5250-5256.
17. Schonherr, E.; Witschprehm, P.; Harrach, B.; Robenek, H.; Rauterberg, J.; Kresse, H. Interaction of biglycan with type-1 collagen. J. Biol. Chem. 1995, 270 (6), 2776-2783.
18. Wiberg, C.; Klatt, A. R.; Wagener, R.; Paulsson, M.; Bateman, J. F.; Heinegard D.; Morgelin, M. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 2003, 278 (39), 37698-37704.
19. Bowe, M. A.; Mendis, D. B.; Fallon J. R. The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J. Cell Biol. 2000, 148 (4), 801-810.
20. Schaefer, L.; Babelova, A.; Kiss, E.; Hausser, H. J.; Baliova, M.; Krzyzankova, M.; Marsche, G., Young, M. F. and others. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 2005, 115 (8), 2223-2233.
21. Tufvesson, E.; Westergren-Thorsson, G. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1 beta and tumor necrosis factor-alpha. J. Cell. Biochem. 2000, 77 (2), 298-309.
22. Chang, M. Y.; Tsoi, C.; Wight, T. N.; Chait, A. Lysophosphatidylcholine Regulates Synthesis of Biglycan and the Proteoglycan Form of Macrophage Colony Stimulating Factor. Arterioscler. Thromb. Vasc. Biol. 2003, 23 (5), 809-815.
23. Schaefer, L.; Beck, K. F.; Raslik, I.; Walpen, S.; Mihalik, D.; Micegova, M.; Macakova, K.; Schonherr, E. and others. Biglycan, a Nitric Oxide-regulated Gene, Affects Adhesion, Growth, and Survival of Mesangial Cells. J. Biol. Chem. 2003, 278 (28), 26227-26237.
24. Ferdinandy, P.; Schulz, R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br. J. Pharmacol. 2003, 138 (4), 532-543.
25. Nathan, C. Inducible nitric oxide synthase: What difference does it make? J. Clin. Invest. 1997, 100 (10), 2417-2423.
26. Kamijo, R.; Harada, H.; Matsujama, T.; Bosland, M.; Gerecitano, J.; Shapiro, D.; Le, J.; Koh, S. I. and others. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994, 263 (5153), 1612-1615.
27. Xie, Q. W.; Cho, H.; Kashiwabara, Y.; Baum, M.; Weidner, J. R.; Elliston, K.; Mumford, R.; Nathan, C. Carboxyl terminus of inducible nitric oxide synthase. Contribution to NADPH binding and enzymatic activity. J. Biol. Chem. 1994, 269 (45), 28500-28505.
28. Blatter, L. A.; Taha, Z.; Mesaros, S.; Shacklock, P. S.; Wier, W. G.; Malinski, T. Simultaneous Measurements of Ca2+ and Nitric Oxide in Bradykinin-Stimulated Vascular Endothelial Cells. Circ. Res. 1995, 76 (5), 922-924.
29. Hogan, B.; Beddington, R.; Constantini, F.; Lacy, E. Manipulating the Mouse Embryo, 2nd ed.; Cold Spring Harbour Laboratory: Cold Spring Harbour, NY, 1996.
30. Puskas, L. G.; Bereczki, E.; Santha, M.; Vigh, L.; Csanadi, G.; Spener, F.; Ferdinandy, P.; Onody, A. and others. Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain. Biochimie 2005, 87 (2), 239-239.
31. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucl. Acids Res. 2001, 29 (9), e45.
32. Bernfield, M.; Kokenyesi, R.; Kato, M.; Hinkes, M. T.; Spring, J.; Gallo, R. L.; Lose, E. J. Biology of the syndecans- A family of transmembrane heparin sulfate proteoglycans. Annu. Rev. Cell Biol. 1992, 8, 365-393.
33. Bernfield, M.; Gotte, M.; Park, P. W.; Reizes, O.; Fitzgerald, M. L.; Lincecum, J.; Zako, M. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 1999, 68, 729-777.
34. Fisher, L. W.; Heegaard, A. M.; Vetter, U.; Vogel, W.; Just, W.; Termine, J. D.; Young, M. F. Human biglycan gene. Putative promoter, intron-exon junctions, and chromosomal localization J. Biol. Chem. 1991, 266 (22), 14371-14377.
35. Bascom, C. C.; Wolfshohl, J. R.; Coffey, R. J., Jr; Madisen, L.; Webb, N. R.; Purchio, A. R.; Derynck, R.; Moses, H. L. Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2. Mol. Cell. Biol. 1989, 9 (12), 5508-15.
36. Eghbali, M.; Tomek, R.; Sukhatme, V. P.; Woods, C. Bhambi, B. Differential effects of transforming growth factor-beta 1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Circ. Res. 1991, 69 (2), 483-90.
37. Murakami, M.; Kusachi, S.; Nakahama, M.; Naito, I.; Murakami, T.; Doi, M.; Kondo, J.; Higashi, T.; Ninomiya, Y.; Tsuji, T. Expression of the alpha 1 and alpha 2 chains of type IV collagen in the infarct zone of rat myocardial infarction. J. Mol. Cell Cardiol. 1998, 30 (6), 1191-202.
38. Kahari, V. M.; Larjava, H.; Uitto, J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-beta 1 up-regulates biglycan (PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J. Biol. Chem. 1991, 266 (16), 10608-15.
39. Ng, C. M.; Cheng, A.; Myers, L. A.; Martinez-Murillo, F.; Jie, C.; Bedja, D.; Gabrielson, K. L.; Hausladen, J. M.; Mecham, R. P.; Judge, D. P.; Dietz, H. C. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J. Clin. Invest. 2004, 114 (11), 1586-92.
40. Neptune, E. R.; Frischmeyer, P. A.; Arking, D. E.; Myers, L.; Bunton, T. E.; Gayraud, B.; Ramirez, F.; Sakai, L. Y.; Dietz, H. C. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 2003, 33 (3) 407-11.
41. Evans, W. H.; De Vuyst, E.; Leybaert, L. The gap junction cellular internet: connexin hemichannels enter the signalling limelight. Biochem. J. 2006, 397, 1-14.
42. Breuer, B.; Schmidt, G.; Kresse, H. Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan. Biochem. J. 1990, 269 (2), 551-554.
43. Schönherr, E.; Jarvelainen, H. T.; Kinsella, M. G.; Sandell, L. J.; Wight, T. N. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb. 1993, 13 (7), 1026-1036.
44. Ungefroren, H.; Krull, N. B. Transcriptional Regulation of the Human Biglycan Gene. J. Biol. Chem. 1996, 271 (26), 15787-15795.
45. Kaji, T.; Yamada, A.; Miyajima, S.; Yamamoto, C.; Fujiwara, Y.; Wight, T. N.; Kinsella, M. G. Cell Density-dependent Regulation of Proteoglycan Synthesis by Transforming Growth Factor-beta 1 in Cultured Bovine Aortic Endothelial Cells. J. Biol. Chem. 2000, 275 (2), 1463-1470.
46. Ahmed, M. S.; Oie, E.; Vinge, L. E.; Yndestad, A.; Andersen, G. O.; Andersson, Y.; Attramadal, T.; Attramadal, H. Induction of myocardial biglycan in heart failure in rats - an extracellular matrix component targeted by AT1 receptor antagonism. Cardiovasc. Res. 2003, 60 (3), 557-568.
47. de Andrade, C. R.; Cotrin, P.; Graner, E.; Almeida, O. P.; Sauk, J. J.; Coletta, R. D. Transforming growth factor -beta1 autocrine stimulation regulates fibroblast proliferation in hereditary gingival fibromatosis. J. Periodontol. 2001, 1726-1733.
48. Lijnen, P. J.; Petrov, V. V.; Fagard, R. H. Induction of Cardiac Fibrosis by Transforming Growth Factor-[beta]1. Mol. Gen. Metabol. 2000, 71 (1-2), 418-435.
49. Melendez, J.; Turner, C.; Avraham, H.; Steinberg, S. F.; Schaefer, E., Sussman, M. A. Cardiomyocyte Apoptosis Triggered by RAFTK/pyk2 via Src Kinase Is Antagonized by Paxillin. J. Biol. Chem. 2004, 279 (51), 53516-53523.
50. Yamamoto, K.; Kusachi, S.; Ninomiya, Y.; Murakami, M.; Doi, M.; Takeda, K.; Shinji, T.; Higashi, T. and others. Increase in the Expression of Biglycan mRNA Expression Co-localized Closely with that of Type I Collagen mRNA in the Infarct Zone After Experimentally-Induced Myocardial Infarction in Rats. J. Mol. Cell. Card. 1998, 30 (9), 1749-1756.
51. Beazely, M. A.; Watts, V. J. Regulatory properties of adenylate cyclases type 5 and 6: A progress report. Eur. J. Pharmacol. 2006, 535 (1-3), 1-12.
52. Michels, J.; Johnson, P. W. M.; Packham, G. Mcl-1. Internat. J. Biochem. Cell Biol. 2005, 37 (2), 267-271.
53. Shimizu-Hirota, R.; Sasamura, H.; Kuroda, M.; Kobayashi, E.; Hayashi, M.; Saruta, T. Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration. Circ. Res. 2004, 94 (8), 1067-1074.
54. Kikuchi, A.; Tomoyasu, H.; Kido, I.; Takahashi, K.; Tanaka, A.; Nonaka, I.; Iwakami, N.; Kamo, I. Haemopoietic biglycan produced by brain cells stimulates growth of microglial cells. J. Neuroimmunol. 2000, 106 (1-2), 78-86.
55. Weber, C. K.; Sommer, G.; Michl, P.; Fensterer, H.; Weimer, M.; Gansauge, F.; Leder, G.; Adler, G.; Gress, T. M., et al. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 2001, 121 (2), 657-667.
56. Lapidos, K. A.; Kakkar, R.; McNally, E. M. The dystrophin glycoprotein complex - Signaling strength and integrity for the sarcolemma. Circ. Res. 2004, 94 (8), 1023-1031.
57. Lefer, A. M.; Tsao, P.; Aoki, N.; Palladino, M. A., Jr. Mediation of cardioprotection by transforming growth factor-beta. Science 1990, 249 (4964), 61-64.
58. Yang, B. C.; Zander, D. S.; Mehta, J. L. Hypoxia-reoxygenation-induced apoptosis in cultured adult rat myocytes and the protective effect of platelets and transforming growth factor-beta-(1). J. Pharmacol. Exp. Ther. 1999, 291 (2), 733-738.
59. Sears, C.; Ashley, E.; Casadei, B. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component? Phil. Trans. R. Soc. Lond. B 2004, 359 (1446), 1021-1044.
60. Danson, E. J.; Choate, J. K.; Paterson, D. J. Cardiac nitric oxide: Emerging role for nNOS in regulating physiological function. Pharmacol. Therap. 2005, 106 (1), 57-74.
61. Stuehr, D. J.; Cho, H. J.; Kwon, N. S.; Weise, M. F.; Nathan, C. F. Purification and Characterization of the Cytokine-Induced Macrophage Nitric Oxide Synthase: An FAD- and FMN-Containing Flavoprotein. PNAS 1991, 88 (17), 7773-7777.
62. Hu, J.; Van Eldik, L. J. Calmodulin and Signal Transduction; Van Eldik, L., Watterson, D. M., Eds.; Academic Press: New York, 1998; pp 288-334.
63. Gribovskaja, I.; Brownlow, K. C.; Dennis, S. J.; Rosko, A. J.; Marletta, M. A.; Stevens-Truss, R. Calcium-Binding Sites of Calmodulin and Electron Transfer by Inducible Nitric Oxide Synthase. Biochemistry 2005, 44 (20), 7593-7601.
64. Torok, K.; Stauffer, K.; Evans, W. H. Connexin 32 of gap junctions contains two cytoplasmic calmodulin-binding domains. Biochem. J. 1997, 326, 479-483.
65. Ahmad, S.; Martin, P. E. M.; Evans, W. H. Assembly of gap junction channels - Mechanism, effects of calmodulin antagonists and identification of connexin oligomerization determinants. Eur. J. Biochem. 2001, 268 (16), 4544-4552.
66. Yoshihara, M.; Adolfsen, B.; Littleton, J. T. Is synaptotagmin the calcium sensor? Curr. Opin. Neurobiol. 2003, 13 (3), 315-323.
67. Weber, T.; Zemelman, B. V.; McNew, J. A.; Westermann, B.; Gmachl, M.; Parlati, F.; Sollner, T. H.; Rothman, J. E. SNARE dependent membrane fusion. Mol. Biol. Cell 1998, 9, 331A-331A.